相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Controlled and uncontrolled allergic asthma in routine respiratory specialist care - a clinical-epidemiological study in Germany
P. Kardos et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis
M. Humbert et al.
ALLERGY (2009)
Safety and tolerability of omalizumab
J. Corren et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
S. Korn et al.
RESPIRATORY MEDICINE (2009)
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Stephen Holgate et al.
RESPIRATORY MEDICINE (2009)
Effectiveness of omalizumab (Xolair (R)) in the first patients treated in real-life practice in France
Mathieu Molimard et al.
RESPIRATORY MEDICINE (2008)
Predicting and evaluating response to omalizumab in patients with severe allergic asthma
J. Bousquet et al.
RESPIRATORY MEDICINE (2007)
The asthma trigger inventory: Validation of a questionnaire for perceived triggers of asthma
Thomas Ritz et al.
PSYCHOSOMATIC MEDICINE (2006)
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists
M Schatz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
J Bousquet et al.
ALLERGY (2005)
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma
JG Ayres et al.
ALLERGY (2004)
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
R Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
R Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Analytic precision and accuracy of commercial immunoassays for specific IgE: Establishing a standard
PB Williams et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
分享论文
